Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes-Reference-Cited by-同舟云学术

Diagnostic significance of flow cytometry scales in diagnostics of myelodysplastic syndromes

Published:2020-10-14 Issue:3 Volume:100 Page:312-321
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Davydova Yulia O.¹^ORCID,Parovichnikova Elena N.²,Galtseva Irina V.¹,Kokhno Alina V.³,Dvirnyk Valentina N.⁴,Kovrigina Alla M.⁵,Obukhova Tatyana N.⁶,Kapranov Nikolay M.¹,Nikiforova Ksenia A.¹,Glinkina Svetlana A.⁵,Troitskaya Vera V.³,Mikhailova Elena A.³,Fidarova Zalina T.³,Moiseeva Tatyana N.⁷,Lukina Elena A.⁸,Tsvetaeva Nina V.⁸,Nikulina Olga F.⁸,Kuzmina Larisa A.⁹,Savchenko Valeriy G.¹⁰

Affiliation:

1. Laboratory of Immunophenotyping National Research Center for Hematology Moscow Russia

2. Chemotherapy Department for Hemoblastoses, Hemopoiesis Depression and BMT National Research Center for Hematology Moscow Russia

3. Intensive High‐Dose Chemotherapy Department for Hemoblastoses and Hematopoiesis Depressions National Research Center for Hematology Moscow Russia

4. Centralized Diagnostic Laboratory National Research Center for Hematology Moscow Russia

5. Department of Pathology National Research Center for Hematology Moscow Russia

6. Karyology Laboratory National Research Center for Hematology Moscow Russia

7. Department of Hematology Advisory National Research Center for Hematology Moscow Russia

8. Department of Orphan Diseases National Research Center for Hematology Moscow Russia

9. Department of Intensive High‐Dose Chemotherapy and BMT National Research Center for Hematology Moscow Russia

10. Head of National Research Center for Hematology Moscow Russia

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.21965

Reference40 articles.

1. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes

2. CD177 enhances the detection of myelodysplastic syndrome by flow cytometry;Alayed K.;American Journal of Clinical Pathology,2020

3. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

4. Low‐Grade Myelodysplastic Syndromes with Preserved CD34+ B‐Cell Precursors (CD34+ Hematogones)

5. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes;Pathology and Oncology Research;2024-07-08

2. Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms;Clinics in Laboratory Medicine;2023-12

3. Clinical Flow Cytometry Analysis in the Setting of Chronic Myeloid Neoplasms and Clonal Hematopoiesis;Clinics in Laboratory Medicine;2023-09

4. Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage;Experimental Hematology;2023-07

5. Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues;Cytometry Part B: Clinical Cytometry;2022-12-20